Home/Neuvivo/Mike McGrath, MD, PhD
MM

Mike McGrath, MD, PhD

Chief Executive Officer, Co-Founder

Neuvivo

Neuvivo Pipeline

DrugIndicationPhase
NP001Amyotrophic Lateral Sclerosis (ALS)Phase 3